SHB and leukemia: Concurrently, Jamalpour et al45 reported a network involving SH2 domain-containing adaptor protein B (SHB), B-cell lymphoma 6 corepressor like 1 (BCORL1), and TET1 that enhances lymphoid traits, vascular development, and leukemia cell survival.